Vitiligo-like lesions and immune checkpoint inhibition therapy: is it truly an adverse event exclusive to patients with melanoma?

Article

Abstract:

Palabras claves:

Autores:

Baniandrés-Rodríguez O., Molina-Lopez I., Ricardo Maria Suárez-Fernández, Rodríguez-Lomba E.

Fuentes:

scopus